EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

In silico Identification of Potential Hepatitis B Virus HBx Inhibitors Through Molecular Docking Analysis

Maryam Aliza, Bibi Haleema

Advances in World Medical Research · 2026

DOI: 10.71204/qbf0ba53 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advances in World Medical Research, 2026. Verfasst von Maryam Aliza und 1 weiteren Autor:innen. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatitis B virus (HBV) remains a major contributor to chronic liver disease worldwide and represents a significant global health challenge. The HBx protein plays an important role in HBV replication and viral pathogenesis and is therefore considered a promising therapeutic target. In the present study, an in silico molecular docking approach was employed to identify potential HBx inhibitors from a selected group of fourteen compounds. The three-dimensional structure of the HBx protein was predicted using the I-TASSER server, and the selected compounds were subjected to molecular docking using PyRx and AutoDock Vina. The docking results revealed that several compounds exhibited favorable predicted binding affinities toward HBx, with SC75741 showing the most favorable docking score (−9.8 kcal/mol), followed by Rutin (−9.1 kcal/mol), Cynarin (−8.6 kcal/mol), and Ledipasvir (−8.4 kcal/mol). Notably, Cynarin, which is not currently an approved anti-HBV drug, demonstrated a favorable docking score and interactions with several important HBx residues, highlighting its potential as a candidate lead compound for further investigation. Overall, the findings suggest that the identified compounds, particularly SC75741, Rutin, Cynarin, and Ledipasvir, may serve as potential candidates for HBx-targeted anti-HBV drug discovery.

Zitieren

APA

Aliza, M., & Haleema, B. (2026). In silico Identification of Potential Hepatitis B Virus HBx Inhibitors Through Molecular Docking Analysis. Advances in World Medical Research. https://doi.org/10.71204/qbf0ba53

Vancouver

Aliza M, Haleema B. In silico Identification of Potential Hepatitis B Virus HBx Inhibitors Through Molecular Docking Analysis. Advances in World Medical Research. 2026. doi:10.71204/qbf0ba53

BibTeX
@article{Aliza2026,
  author = {Aliza, Maryam and Haleema, Bibi},
  title = {In silico Identification of Potential Hepatitis B Virus HBx Inhibitors Through Molecular Docking Analysis},
  journal = {Advances in World Medical Research},
  year = {2026},
  doi = {10.71204/qbf0ba53}
}
Kostenlos starten →